scispace - formally typeset
M

Mark Pinese

Researcher at Garvan Institute of Medical Research

Publications -  83
Citations -  12721

Mark Pinese is an academic researcher from Garvan Institute of Medical Research. The author has contributed to research in topics: Cancer & Pancreatic cancer. The author has an hindex of 33, co-authored 71 publications receiving 9551 citations. Previous affiliations of Mark Pinese include University of New South Wales.

Papers
More filters
Journal ArticleDOI

Sca1+/CD31−/PDGFRa+ Cardiac Stem Cells are from an Epicardial/Mesodermal but not Neural-crest, Cardiomyocyte or Bone-marrow Origin

TL;DR: CCFU-F endogenous cardiac stem cells are derived from an epicardial and mesodermal origin but not from the neural-crest, dedifferentiated cardiomyocytes or adult BM, as well as a possible bone-marrow origin.
Journal ArticleDOI

Introme accurately predicts the impact of coding and noncoding variants on gene splicing, with clinical applications

TL;DR: Introme as discussed by the authors uses machine learning to integrate predictions from several splice detection tools, additional splicing rules, and gene architecture features to comprehensively evaluate the likelihood of a variant impacting splicing.
Journal ArticleDOI

Author Correction: Pan-cancer analysis of whole genomes

Lauri A. Aaltonen, +1320 more
- 25 Jan 2023 - 
Proceedings ArticleDOI

Abstract A02: Assessment of germline cancer predisposition genes in 392 unselected pancreatic cancer patients

TL;DR: 5.9% of PC patients with predominantly sporadic disease have a pathogenic germline mutation in cancer predisposition genes associated with PC risk, however, carrier status did not significantly affect age at diagnosis, survival, personal or family history of malignancy in this cohort.